University of Washington
It s easy to find your locality s coronavirus vaccination rate, but what about its vaccine hesitancy rate, or local interest in vaccination? Two new interactive tools reveal those numbers.
Â
Facebook; the other shows the relative interest in vaccination shown by online searches.Â
Â
The Facebook-gathered data are in interactive maps from theÂ
University of Washington, showing what counties (and even what Zip codes) are most hesitant to get a shot.
The maps by the university sÂ
Institute for Health Metrics and Evaluation reflect answers to this question: If a vaccine to prevent Covid-19 were offered to you today, would you choose to get vaccinated? The answers are Definitely, Probably, Probably not and Definitely not. People giving one of the last three answers are considered vaccine-hesitant.
Metcalfe-county
Kentucky
United-states
University-of-washington
Washington
Lewis-county
Ballard-county
Nicholas-county
Boston
Massachusetts
Jackson-county
Spencer-county
E-Mail
Los Angeles, Calif. - The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced that the Camostat treatment group of the COVID-19 outpatient treatment study, ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, will not move to phase 3. ACTIV-2 includes both phase 2 and phase 3 evaluations of multiple investigational agents for treating early COVID-19 in a single trial. For information about the trial, please visit the study website.
Camostat, provided by Sagent Pharmaceuticals (a Nichi-Iko Group Company), is an orally administered protease inhibitor that was dosed as 200 mg every six hours for seven days. The Camostat arm of ACTIV-2 completed phase 2 enrollment with 224 participants on April 26, 2021. When the Therapeutic and Prevention Data and Safety Monitoring Board (DSMB) met on June 14, 2021 to review the data and determine whether Camostat would advance to phase 3, they determined that while there were no safet
Los-angeles
National-institutes-of-health
National-institute-of-allergy
Clinical-trials-group
Sagent-pharmaceuticalsa-nichi-iko-group-company
Trials-group
Monoclonal-antibodies
Sagent-pharmaceuticals
Nichi-iko-group-company
Prevention-data
Safety-monitoring-board
CDC director says hospitalizations among seniors are declining as more than half of the age group is fully vaccinated
CNBC 2 hrs ago Nate Rattner
About 75% of Americans 65 and older have received at least one vaccine shot and more than half are fully vaccinated, according to CDC data.
CDC Director Rochelle Walensky said emergency department visits and hospitalizations associated with that 65 and older demographic are declining.
The U.S. is reporting about 64,600 daily new Covid cases and nearly 800 deaths, and averaging just over 3 million vaccine shots per day.
As the U.S. continues to increase the pace of its vaccination campaign, now averaging more than 3 million shots per day, those in the most vulnerable age group are leading the way. About 75% of Americans 65 and older have received at least one shot, according to Centers for Disease Control and Prevention data, and more than half are fully vaccinated.
United-states
White-house
District-of-columbia
Americans
Cyrus-shahphar
Rochelle-walensky
Centers-for-disease
Johns-hopkins-university
Disease-control
Prevention-data
Easter-sunday
Director-cyrus-shahphar